Advertisement

Japanese Journal of Ophthalmology

, Volume 60, Issue 3, pp 198–205 | Cite as

Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population

  • Mikihide Ogasawara
  • Akira Meguro
  • Tsutomu SakaiEmail author
  • Nobuhisa Mizuki
  • Toshiyuki Takahashi
  • Kazuo Fujihara
  • Hiroshi Tsuneoka
  • Keigo Shikishima
Clinical Investigation

Abstract

Purpose

Neuromyelitis optica (NMO) is an inflammatory demyelinating disorder that generally affects the optic nerve and spinal cord. The etiology of this disease is still uncertain, but autoantibodies to aquaporin-4 (AQP4) are specific and pathogenic for NMO. Recent studies show that AQP4 gene variants are associated with NMO. In this study, we assessed the contribution of AQP4 genetic variants to susceptibility to anti-AQP4 antibody (AQP4-Ab)-positive NMO in a Japanese population.

Methods

The subjects were 16 patients with AQP4-Ab-positive NMO (13 sporadic cases, and 3 familial cases from 2 families) and 255 healthy controls. All coding exons of AQP4 were sequenced and five tag single-nucleotide polymorphisms (SNPs) in AQP4 were genotyped. We also performed an imputation analysis to evaluate the potential association of un-genotyped SNPs in AQP4.

Results

Known or novel mutations were not detected in any coding exon regions. The T allele frequency of polymorphism (−810 bp (C/T): rs2075575) of the promoter region in patients with AQP4-Ab-positive NMO was significantly higher than that in controls (50.0 vs 25.7 %, P = 0.0036, Pc = 0.018 odds ratio = 2.89). No other tag or imputed SNPs were significant.

Conclusions

These findings suggest that the T allele of rs2075575 is a risk for AQP4-Ab-positive NMO. However, the results are the opposite of a previous study in the southern Han Chinese population, and therefore further genetic studies are needed to determine the possible contribution of the AQP4 region to development of NMO.

Keywords

AQP4 NMO SNP 

Notes

Conflicts of interest

M. Ogasawara, None; A. Meguro, None; T. Sakai, None; N. Mizuki, None; T. Takahashi, None; K. Fujihara, None; H. Tsuneoka, None; K. Shikishima, None.

References

  1. 1.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130:1194–205.CrossRefPubMedGoogle Scholar
  2. 2.
    Misu T, Fujihara K, Itoyama Y. Neuromyelitis optica and anti-aquaporin 4 antibody—an overview. Brain Nerve. 2008;60:527–37.PubMedGoogle Scholar
  3. 3.
    Cabrera-Gómez JA, Kurtzke JF, González-Quevedo A, Lara-Rodríguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol. 2009;256:35–44.CrossRefPubMedGoogle Scholar
  4. 4.
    Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Matiello M, Kim HJ, Kim W, Brum DG, Barreira AA, Kingsbury DJ, et al. Familial neuromyelitis optica. Neurology. 2010;75:310–5.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Yoshimine S, Sakai T, Ogasawara M, Shikishima K, Tsuneoka H, Tanaka K. Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter. Jpn J Ophthalmol. 2011;55:647–50.CrossRefPubMedGoogle Scholar
  7. 7.
    Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain. 1999;122:1689–96.CrossRefPubMedGoogle Scholar
  8. 8.
    Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N, et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens. 2009;73:171–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Zéphir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M, et al. Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler. 2009;15:571–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Kim HJ, Park HY, Kim E, Lee KS, Kim KK, Choi BO, et al. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis. 2010;37:349–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Matiello M, Schaefer-Klein JL, Hebrink DD, Kingsbury DJ, Atkinson EJ, Weinshenker BG, NMO Genetics Collaborators. Genetic analysis of aquaporin-4 in neuromyelitis optica. Neurology. 2011;77:1149–55.CrossRefPubMedGoogle Scholar
  12. 12.
    Mai W, Hu X, Lu Z, Qiu W, Peng F, Wang Y. Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system. J Neuroimmunol. 2013;255:75–80.CrossRefPubMedGoogle Scholar
  13. 13.
    Park TJ, Kim JH, Kim HJ, Bae JS, Cheong HS, Park BL, et al. Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population. Gene. 2014;536:302–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Li Y, Willer CJ, Sanna S, Abecasis GR. Genotype imputation. Annu Rev Genom Hum Genet. 2009;10:387–406.CrossRefGoogle Scholar
  15. 15.
    Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816–34.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491:56–65.CrossRefGoogle Scholar
  17. 17.
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:423–50.CrossRefGoogle Scholar
  18. 18.
    Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Frigeri A, Gropper MA, Turck CW, Verkman AS. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci. 1995;92:4328–31.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS. Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci. 1995;108:2993–3002.PubMedGoogle Scholar
  21. 21.
    Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci. 2012;109:1245–50.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473–7.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012;9:14.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53:1107–14.CrossRefPubMedGoogle Scholar
  25. 25.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235–43.CrossRefPubMedGoogle Scholar
  26. 26.
    Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, et al. Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008;205:2473–81.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, Nakano M, et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport. 2009;20:508–12.CrossRefPubMedGoogle Scholar
  28. 28.
    Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci. 1994;91:13052–6.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Lu M, Lee MD, Smith BL, Jung JS, Agre P, Verdijk MA, et al. The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain. Proc Natl Acad Sci. 1996;93:10908–12.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sorani MD, Zador Z, Hurowitz E, Yan D, Giacomini KM, Manley GT. Novel variants in human Aquaporin-4 reduce cellular water permeability. Hum Mol Genet. 2008;17:2379–89.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Chu JY, Huang W, Kuang SQ, Wang JM, Xu JJ, Chu ZT, et al. Genetic relationship of populations in China. Proc Natl Acad Sci. 1998;95:11763–8.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–320.CrossRefGoogle Scholar
  33. 33.
    Zhang F, Su B, Zhang YP, Jin L. Genetic studies of human diversity in East Asia. Philos Trans R Soc Lond B Biol Sci. 2007;362:987–95.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Xue F, Wang Y, Xu S, Zhang F, Wen B, Wu X, et al. A spatial analysis of genetic structure of human populations in China reveals distinct difference between maternal and paternal lineages. Eur J Hum Genet. 2008;16:705–17.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Ophthalmological Society 2016

Authors and Affiliations

  • Mikihide Ogasawara
    • 1
  • Akira Meguro
    • 2
  • Tsutomu Sakai
    • 1
    Email author
  • Nobuhisa Mizuki
    • 2
  • Toshiyuki Takahashi
    • 3
    • 4
  • Kazuo Fujihara
    • 5
  • Hiroshi Tsuneoka
    • 1
  • Keigo Shikishima
    • 1
  1. 1.Department of OphthalmologyJikei University School of MedicineTokyoJapan
  2. 2.Department of OphthalmologyYokohama City University School of MedicineYokohamaJapan
  3. 3.Department of NeurologyTohoku University Graduate School of MedicineSendaiJapan
  4. 4.Department of NeurologyYonezawa National HospitalYonezawaJapan
  5. 5.Department of Multiple Sclerosis TherapeuticsTohoku University Graduate School of MedicineSendaiJapan

Personalised recommendations